COMPOSITIONS AND METHODS FOR TREATING MYASTHENIA GRAVIS

Patent Number: WO-2024068862-A1

Publication Year: 2024

Application Year: 2023

Priority Year: 2022

Jurisdictions: WO

Status: N/A

Inventors:

PEDERSEN THOMAS HOLM BOLD JANE MARY GRØNNEBÆK THOMAS SKJÆRLUND BASTIAS JORGE ARMANDO QUIROZ HUTCHISON JOHN BLUNDELL NIELSEN OLE BÆKGAARD KNUTSEN LARS J S NORDHOLM LARS KELLY NICHOLAS MICHAEL CHIN EVA ROSE JENSEN KLAUS GJERVIG FLAGSTAD PETER

Applicants:

  1. NMD PHARMA AS
  2. [NORA names: Other Companies; Private Research]

Abstract

Disclosed herein are methods of treatment for myasthenia gravis (MG) that involve administering (2S)-2-[4-bromo-2-(1,2-oxazol-3-yl)phenoxy]propanoic acid, or a pharmaceutical composition thereof, to a patient suffering from symptoms of MG. Pharmaceutical compositions and kits-to-parts including (2S)-2-[4-bromo-2-(1,2-oxazol-3-yl)phenoxy]propanoic acid are also disclosed.

Patent Family Records (1)

COMPOSITIONS AND METHODS FOR TREATING MYASTHENIA GRAVIS

NMD PHARMA AS PEDERSEN THOMAS HOLM, BOLD JANE MARY, GRØNNEBÆK THOMAS SKJÆRLUND, (...more)

2024, WO-2024068862-A1

Data Provider: Digital Science